Kurt Pike
Senior Director - External Innovation Johnson & Johnson
Kurt Pike is a highly experienced Drug Hunter and Medicinal Chemist who currently holds the role of Senior Director, External Innovation in J&J Innovative Medicines. Located at the EMEA Innovation Centre in London UK, Kurt is looking to connect with Entrepreneurs and Innovators to identify future collaboration opportunities, aligned with J&J’s strategic focus, to bring forward innovative new therapies to transform human health.
Kurt has worked in the Pharmaceutical Industry for ~30 years and has significant experience in both BD / External Innovation roles (~10 years, across both J&J and AstraZeneca) and as a Medicinal Chemist (>20 years, AstraZeneca). In these roles he has executed multiple collaboration & licensing deals and led internal Chemistry efforts resulting in the delivery of multiple clinical candidates across different therapy areas.
Seminars
Discover what drives licensing decisions, investment strategies, and M&A activity, from making your ADC programmes attractive to where the next shift in the industry is heading. As large pharma companies increasingly compete for differentiated ADC platforms and clinical-stage assets, understanding the data, innovation, and risk factors behind successful deals has never been more important.
- Discussion 1 – Building the Next Wave of ADC Drugs Through Biopharma Acquisitions & Technology Scouting
- Discussion 2 – Turbocharging Biotech Innovation & Differentiation to Achieve Successful Fund Raising Rounds
